Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 1, 2005, Pages 55-60

  Vachier, Isabelle ^a   Bonnans, Caroline ^a   Chavis, Claude ^a   Farce, Martine ^a   Godard, Philippe ^a   Bousquet, Jean ^a   Chanez, Pascal ^a,b  

^a CHU   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

asthma; IL 8; induced sputum; Lipoxins; LTB 4

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXIN A;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SPUTUM; VALIDATION PROCESS;

ADULT; ASTHMA; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOTRIENE B4; LIPOXINS; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 11344278774     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.09.038     Document Type: Article

References (43)

1. C. Serhan, M. Hamberg, and B. Samuelsson Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes Proc Natl Acad Sci U S A 81 1984 5335 5339
2. D. Steinhilber, and H.J. Roth New series of lipoxins isolated from human eosinophils FEBS Lett 255 1989 143 148
3. C. Chavis, P. Godard, A. Crastes de Paulet, and M. Damon Formation of lipoxins and leukotrienes by human alveolar macrophages incubated with 15(S)-HETE: a model for cellular cooperation between macrophages and airway epithelial cells Eicosanoids 5 1992 203 211
4. C. Chavis, I. Vachier, P. Chanez, J. Bousquet, and P. Godard 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors J Exp Med 183 1996 1633 1643
5. J. Claria, and C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc Natl Acad Sci U S A 92 1995 9475 9479
6. J. Claria, M.H. Lee, and C.N. Serhan Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation Mol Med 2 1996 583 596
7. T.H. Lee, A.E. Crea, V. Gant, B.W. Spur, B.E. Marron, and K.C. Nicolaou Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases Am Rev Respir Dis 141 1990 1453 1458
8. B.D. Levy, M. Romano, H.A. Chapman, J.J. Reilly, J. Drazen, and C.N. Serhan Human alveolar macrophages have 15-lipoxygenase and generate15(S)- hydroxy-5, 8,11-cis-13-trans-eicosatetraenoic acid and lipoxins J Clin Invest 92 1993 1572 1579
9. C. Bonnans, I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez Lipoxins are potential endogenous antiinflammatory mediators in asthma Am J Respir Crit Care Med 165 2002 1531 1535
10. C.N. Serhan Lipoxins: biosynthesis and evidence for their involvement in respiratory disease C. Robinson Lipid mediators in allergic diseases of the respiratory tract 1994 CRC Press Boca Raton 65 78
11. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat Immunol 2 2001 612 619
12. C. Godson, and H.R. Brady Lipoxins: novel anti-inflammatory therapeutics? Curr Opin Investig Drugs 1 2000 380 385
13. S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, and G. Berlasconi Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J Am Soc Nephrol 13 2002 2497 2507
14. I. Vachier, C. Chavis, M. Majori, M. Farce, J. Bousquet, and P. Godard Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma J Allergy Clin Immunol 107 2001 824 831
15. B.D. Levy, G.T. De Sanctis, P.R. Devchand, E. Kim, K. Ackerman, and B.A. Schmidt Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4) Nat Med 8 2002 1018 1023
16. P.J. Barnes Anti-inflammatory actions of glucocorticoids: molecular mechanisms Clin Sci 94 1998 557 572
17. M. Dykewics, P. Greenberger, R. Patterson, and J. Halwig Natural history of asthma in patients requiring long-term systemic corticosteroids Arch Intern Med 146 1986 2369 2372
18. S. Wenzel, S. Szefler, D. Leung, S. Sloan, M. Rex, and R. Martin Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids Am J Respir Crit Care Med 156 1997 737 743
19. M. Pizzichini, E. Pizzichini, L. Clelland, A. Efthimiadis, I. Pavord, and J. Dolovich Prednisone-dependent asthma: inflammatory indices in induced sputum Eur Respir J 13 1999 15 21
20. B. Vrugt, S. Wilson, J. Underwood, A. Bron, R. De Bruyn, and P. Bradding Mucosal inflammation in severe glucocorticoid-dependent asthma Eur Respir J 13 1999 1245 1252
21. A. Jatakanon, C. Uasuf, W. Maziak, S. Lim, K. Chung, and P. Barnes Neutrophilic inflammation in severe persistent asthma Am J Respir Crit Care Med 160 1999 1532 1539
22. S. Wenzel, L. Schwartz, E. Langmack, J. Halliday, J. Trudeau, and R. Gibbs Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
23. L. Teran, M. Carroll, A. Frew, A. Redington, D. Davies, and I. Lindley Leukocyte recruitment after local endobronchial allergen challenge in asthma: relationship to procedure and to airway interleukin-8 release Am J Respir Crit Care Med 15 1996 469 476
24. P. Borgeat, and P.H. Naccache Biosynthesis and biological activity of leukotriene B4 Clin Biochem 23 1990 459 468
25. S.W. Crooks, D.L. Bayley, S.L. Hill, and R.A. Stockley Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4 Eur Respir J 15 2000 274 280
26. M. Profita, A. Sala, L. Riccobono, E. Pace, A. Paterno, and S. Zarini 15(S)-HETE modulates LTB(4) production and neutrophil chemotaxis in chronic bronchitis Am J Physiol Cell Physiol 279 2000 C1249 C1258
27. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Official statement of the American Thoracic Society adopted by the ATS Board of Directors, November 1986 Am Rev Respir Dis 136 1987 225 244
28. WHO/NHLBI Workshop report. Global strategy for asthma management and prevention. Publication #02-3659. Bethesda (MD): National Institutes of Health/National Heart, Lung, and Blood Institute; 2002.
29. R. Gagliardo, P. Chanez, A. Vignola, J. Bousquet, I. Vachier, and P. Godard Glucocorticoid receptor alpha and beta in glucocorticoid-dependent asthma Am J Respir Crit Care Med 162 2000 7 13
30. R. Pauwels Global initiative for chronic obstructive lung diseases (GOLD): time to act Eur Respir J 18 2001 901 902
31. J. Kips, J. Fahy, F. Hargreave, P. Ind, and J. In't Veen Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma Eur Respir J Suppl 26 1998 9S 12S
32. P.L. Paggiaro, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, and P. Maestrelli Sputum induction Eur Respir J Suppl 37 2002 3S 8S
33. I. Pin, P. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J. Denburg, and F. Hargreave Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1992 25 29
34. E. Pizzichini, M.M. Pizzichini, R. Leigh, R. Djukanovic, and P.J. Sterk Safety of sputum induction Eur Respir J Suppl 37 2002 9S 18S
35. D. Stanescu, A. Sanna, C. Veriter, S. Kostianev, P.G. Calcagni, and L.M. Fabbri Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils Thorax 51 1996 267 271
36. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Eur Respir J 22 2003 470 477
37. M.M. Kelly, V. Keatings, R. Leigh, C. Peterson, J. Shute, and P. Venge Analysis of fluid-phase mediators Eur Respir J Suppl 37 2002 24s 39s
38. M. Romano, G. Luciotti, S. Gangemi, F. Marinucci, C. Prontera, and E. D'Urbano Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins Lab Invest 82 2002 1253 1254
39. J.B. Richman-Eisenstat, P.G. Jorens, C.A. Hebert, I. Ueki, and J.A. Nadel Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases Am J Physiol 264 1993 L413 L418
40. C.N. Serhan Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53 1997 107 137
41. R. Taha, R. Olivenstein, T. Utsumi, P. Ernst, P.J. Barnes, and I.W. Rodger Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 636 640
42. J. Hukkanen, O. Pelkonen, J. Hakkola, and H. Raunio Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung Crit Rev Toxicol 32 2002 391 411
43. J. Bylund, J. Ericsson, and E.H. Oliw Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS Anal Biochem 265 1998 55 68